Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  strontium chloride Sr 89
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-9 of 9 for your search:
Start Over
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: ID00-156, U10CA045809, P30CA016672, MDA-ID-00156, NCI-3410, CDR0000068897, NCI-2009-00009, 3410, NCT00024167
Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases
Phase: Phase III
Type: Treatment
Status: Completed
Age: any age
Sponsor: Other
Protocol IDs: EORTC-30921, NCT00002503
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0517, CDR0000491233, NCI-2009-00727, NCT00365105
Phase I/II Study of Strontium-89 in the Treatment of Patients with Endocrine-Resistant Prostate Cancer with Painful Osseous Metastases
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: RTOG-8821, RTOG-88-21
Phase II Study of Sn-117m DTPA versus Strontium-89 in Patients with Painful Bone Metastases Secondary to Prostate Cancer (Summary Last Modified 08/1999)
Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: DIATIDE-117-30, UCMC-97012201
Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2003-0922, MDA-2003-0922, NCI-6459, NCI-2009-00062, CDR0000360625, 2 U10 CA45809-17, 6459, NCT00081159
A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: GUPPS2, NCT00156884
Phase II Randomized Study of Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Patients With Hormone-Refractory Prostate Cancer Metastatic to Bone. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information.
Phase: Phase II
Type: Treatment
Status: Unknown
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: CRUK-TRAPEZE-2100, PR2100, EUDRACT-2004-002295-41, EU-20782, ISRCTN12808747, SANOFI-AVENTIS-CRUK-TRAPEZE-2100, NOVARTIS-CRUK-TRAPEZE-2100, NCT00554918
Start Over